ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65 | -66.5% | 18,023 | -69.2% | 0.00% | -50.0% |
Q1 2023 | $194 | +71.7% | 58,507 | +100.5% | 0.00% | +100.0% |
Q4 2022 | $113 | -100.0% | 29,180 | -79.5% | 0.00% | -75.0% |
Q3 2022 | $346,000 | +276.1% | 142,471 | +206.9% | 0.00% | +300.0% |
Q2 2022 | $92,000 | +178.8% | 46,423 | +144.7% | 0.00% | – |
Q1 2021 | $33,000 | -26.7% | 18,968 | -18.3% | 0.00% | – |
Q4 2020 | $45,000 | -87.0% | 23,210 | -80.4% | 0.00% | -100.0% |
Q2 2020 | $346,000 | -4.4% | 118,200 | -6.0% | 0.00% | 0.0% |
Q1 2020 | $362,000 | – | 125,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |